Sirolimus-eluting coronary stents: a review

被引:45
作者
Abizaid, Alexandre [1 ]
机构
[1] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil
关键词
angioplasty; restenosis; percutaneous coronary intervention; rapamycin; sirolimuseluting stent;
D O I
10.2147/vhrm.2007.3.2.191
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The sirolimus-eluting coronary stent received CE Mark approval in Europe in April 2002. In the US, FDA approval followed in April 2003. Since the preliminary results from the First-in-Man feasibility study were presented, several randomized, controlled trials have documented the profound antiproliferative effects of sirolimus, a macrolide antibiotic and potent cytostatic inhibitor of smooth muscle cell proliferation. Subsequently, the body of clinical evidence was increased by the second wave of evidence from trials in more complex lesions (such as in-stent restenosis, small vessels, chronic total occlusions) and "high-risk" patients such as those with diabetes. More recently we have had the opportunity to compare the two commercially available drug-eluting stents following the presentation of data from six head-to-head trials. As a result of numerous single and multi-center, national and international studies in which the safety and efficacy of sirolimus-eluting coronary stents have been subjected to close scrutiny, the global interventional cardiology community now has a wealth of evidence in support of the use of this technology resulting in dramatically improved patient outcomes after percutaneous intervention.
引用
收藏
页码:191 / 201
页数:11
相关论文
共 64 条
  • [1] A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis -: Results of the restenosis intrastent:: Balloon angioplasty versus elective sirolimus-eluting stenting (RIBS-II) trial
    Alfonso, Fernando
    Perez-Vizcayno, Maria-Jose
    Hernandez, Rosana
    Bethencourt, Armando
    Marti, Vicens
    Lopez-Minguez, Jose R.
    Angel, Juan
    Mantilla, Ramon
    Moris, Cesar
    Cequier, Angel
    Sabate, Manel
    Escaned, Javier
    Moreno, Raul
    Bañuelos, Camino
    Suarez, Alfonso
    Macaya, Carlos
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (11) : 2152 - 2160
  • [2] Full metal jacket (stented length ≥64 mm) using drug-eluting stents for de novo coronary artery lesions
    Aoki, J
    Ong, ATL
    Granillo, GAR
    McFadden, EP
    van Mieghem, CAG
    Valgimigli, M
    Tsuchida, K
    Sianos, G
    Regar, E
    de Jaegere, PPT
    van der Giessen, WJ
    de Feyter, PJ
    van Domburg, RT
    Serruys, PW
    [J]. AMERICAN HEART JOURNAL, 2005, 150 (05) : 994 - 999
  • [3] Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries - A randomized trial
    Ardissino, D
    Cavallini, C
    Bramucci, E
    Indolfi, C
    Marzocchi, A
    Manari, A
    Angeloni, G
    Carosio, G
    Bonizzoni, E
    Colusso, S
    Repetto, M
    Merlini, PA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (22): : 2727 - 2734
  • [4] Risk of thrombosis with the use of sirolimus-eluting stents for percutaneous coronary intervention (from registry and clinical trial data)
    Bavry, AA
    Kumbhani, DJ
    Helton, TJ
    Bhatt, DL
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (12) : 1469 - 1472
  • [5] DESIGN AND SYNTHESIS OF A RAPAMYCIN-BASED HIGH-AFFINITY BINDING FKBP12 LIGANDS
    CHAKRABORTY, TK
    WEBER, HP
    NICOLAOU, KC
    [J]. CHEMISTRY & BIOLOGY, 1995, 2 (03): : 157 - 161
  • [6] FK506 AND RAPAMYCIN - NOVEL PHARMACOLOGICAL PROBES OF THE IMMUNE-RESPONSE
    CHANG, JY
    SEHGAL, SN
    BANSBACH, CC
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1991, 12 (06) : 218 - 223
  • [7] Drug-eluting stent thrombosis - Increasingly recognized but too frequently overemphasized
    Colombo, Antonio
    Corbett, Simon J.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (01) : 203 - 205
  • [8] de Lezo JS, 2005, J AM COLL CARDIOL, V45, p75A
  • [9] Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients
    Dibra, A
    Kastrati, A
    Mehilli, J
    Pache, J
    Schühlen, H
    von Beckerath, N
    Ulm, K
    Wessely, R
    Dirschinger, J
    Schömig, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (07) : 663 - 670
  • [10] Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle
    Gallo, R
    Padurean, A
    Jayaraman, T
    Marx, S
    Rogue, M
    Adelman, S
    Chesebro, J
    Fallon, J
    Fuster, V
    Marks, A
    Badimon, JJ
    [J]. CIRCULATION, 1999, 99 (16) : 2164 - 2170